Mirati Therapeutics Inc. (MRTX)
NASDAQ: MRTX
· Real-Time Price · USD
58.70
-0.10 (-0.17%)
At close: Jan 22, 2024, 9:00 PM
Mirati Therapeutics Revenue
Mirati Therapeutics reported an annual revenue of $12.44M, reflecting a -82.75% growth. For the quarter ending September 30, 2023, Mirati Therapeutics generated $16.4M in revenue.
Revenue (ttm)
$12.44M
Revenue Growth
-82.75%
Price / Sales Ratio
204.88
Revenue / Employee
$21.19K
Employees
587
Market Cap
4.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2022 | 12.44M | -82.75% |
| Dec 31, 2021 | 72.09M | +438.08% |
| Dec 31, 2020 | 13.4M | n/a |